Virpax Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervo…

Biotechnology
US, Berwyn [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Virpax Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of VRPX's Analysis
CIK: 1708331 CUSIP: 928251206 ISIN: US9282512063 LEI: - UEI: -
Secondary Listings
VRPX has no secondary listings inside our databases.